Literature DB >> 2146924

Importance of nicotinamide as an NAD precursor in the human erythrocyte.

V Micheli1, H A Simmonds, S Sestini, C Ricci.   

Abstract

The effect of variation in the concentration of inorganic phosphate and of the pyridine precursors nicotinamide (NAm) and nicotinic acid (NA) on pyridine nucleotide synthesis was studied using intact human erythrocytes. A wide range of incubation times was employed. The results showed that under physiological conditions the rate of synthesis of NAD from NAm exceeded that from NA twofold, while the reverse situation pertained at higher and unphysiological substrate levels. The two pathways had different regulation points. For NAm the rate-limiting factor was the initial step, namely its conversion into the mononucleotide, while for NA it lay at the second step, conversion of NA mononucleotide (NAMN) to its adenine dinucleotide. At physiological substrate levels the uptake of NA and conversion to NAMN were rapid, while the uptake and conversion of NAm were time dependent. This process was stimulated significantly by inorganic phosphate only for NAm. These results indicate that while NA is the predominant precursor of human erythrocyte NAD at high (unphysiological) substrate and phosphate levels, NAm is more efficient as an NAD precursor under physiological conditions, suggesting an important and hitherto unrecognized role for nicotinamide in NAD synthesis in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146924     DOI: 10.1016/0003-9861(90)90609-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients.

Authors:  Lynette D Fairbanks; Gabriella Jacomelli; Vanna Micheli; Tina Slade; H Anne Simmonds
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 2.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

3.  Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.

Authors:  Carola Huthmacher; Andreas Hoppe; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  BMC Syst Biol       Date:  2010-08-31

4.  Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition.

Authors:  Lisa M Giammona; Swapna Panuganti; Jan M Kemper; Pani A Apostolidis; Stephan Lindsey; Eleftherios T Papoutsakis; William M Miller
Journal:  Exp Hematol       Date:  2009-08-26       Impact factor: 3.084

5.  Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes.

Authors:  Keisuke Hikosaka; Masashi Ikutani; Masayuki Shito; Kohei Kazuma; Maryam Gulshan; Yoshinori Nagai; Kiyoshi Takatsu; Katsuhiro Konno; Kazuyuki Tobe; Hitoshi Kanno; Takashi Nakagawa
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

6.  Data mining of the transcriptome of Plasmodium falciparum: the pentose phosphate pathway and ancillary processes.

Authors:  Zbynek Bozdech; Hagai Ginsburg
Journal:  Malar J       Date:  2005-03-18       Impact factor: 2.979

7.  Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues.

Authors:  Valerio Mori; Adolfo Amici; Francesca Mazzola; Michele Di Stefano; Laura Conforti; Giulio Magni; Silverio Ruggieri; Nadia Raffaelli; Giuseppe Orsomando
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

Review 8.  Nicotinamide adenine dinucleotide and the sirtuins caution: Pro-cancer functions.

Authors:  Raymond D Palmer; Mauro Vaccarezza
Journal:  Aging Med (Milton)       Date:  2021-11-30

9.  Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis.

Authors:  W Todd Penberthy
Journal:  PPAR Res       Date:  2009-05-17       Impact factor: 4.964

10.  Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors.

Authors:  Sei-Ichi Tanuma; Kiyotaka Katsuragi; Takahiro Oyama; Atsushi Yoshimori; Yuri Shibasaki; Yasunobu Asawa; Hiroaki Yamazaki; Kosho Makino; Miwa Okazawa; Yoko Ogino; Yoshimi Sakamoto; Miyuki Nomura; Akira Sato; Hideaki Abe; Hiroyuki Nakamura; Hideyo Takahashi; Nobuhiro Tanuma; Fumiaki Uchiumi
Journal:  Molecules       Date:  2020-08-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.